Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 1
2019 5
2020 4
2021 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
The potential and controversy of targeting STAT family members in cancer.
Verhoeven Y, Tilborghs S, Jacobs J, De Waele J, Quatannens D, Deben C, Prenen H, Pauwels P, Trinh XB, Wouters A, Smits ELJ, Lardon F, van Dam PA. Verhoeven Y, et al. Semin Cancer Biol. 2020 Feb;60:41-56. doi: 10.1016/j.semcancer.2019.10.002. Epub 2019 Oct 9. Semin Cancer Biol. 2020. PMID: 31605750 Free article. Review.
The role of Nuclear Factor-kappa B signaling in human cervical cancer.
Tilborghs S, Corthouts J, Verhoeven Y, Arias D, Rolfo C, Trinh XB, van Dam PA. Tilborghs S, et al. Among authors: verhoeven y. Crit Rev Oncol Hematol. 2017 Dec;120:141-150. doi: 10.1016/j.critrevonc.2017.11.001. Epub 2017 Nov 7. Crit Rev Oncol Hematol. 2017. PMID: 29198328 Review.
Targeting hedgehog signaling in pancreatic ductal adenocarcinoma.
Quatannens D, Verhoeven Y, Van Dam P, Lardon F, Prenen H, Roeyen G, Peeters M, Smits ELJ, Van Audenaerde J. Quatannens D, et al. Among authors: verhoeven y. Pharmacol Ther. 2022 Aug;236:108107. doi: 10.1016/j.pharmthera.2022.108107. Epub 2022 Jan 7. Pharmacol Ther. 2022. PMID: 34999181 Review.
RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review.
van Dam PA, Verhoeven Y, Jacobs J, Wouters A, Tjalma W, Lardon F, Van den Wyngaert T, Dewulf J, Smits E, Colpaert C, Prenen H, Peeters M, Lammens M, Trinh XB. van Dam PA, et al. Among authors: verhoeven y. Int J Mol Sci. 2019 May 2;20(9):2183. doi: 10.3390/ijms20092183. Int J Mol Sci. 2019. PMID: 31052546 Free PMC article. Review.
The immunologic aspects in hormone receptor positive breast cancer.
Oner G, Altintas S, Canturk Z, Tjalma W, Van Berckelaer C, Broeckx G, Zwaenepoel K, Tholhuijsen M, Verhoeven Y, Berneman Z, Peeters M, Pauwels P, van Dam PA. Oner G, et al. Among authors: verhoeven y. Cancer Treat Res Commun. 2020;25:100207. doi: 10.1016/j.ctarc.2020.100207. Epub 2020 Aug 29. Cancer Treat Res Commun. 2020. PMID: 32896829 Free article. Review.
Bone metastases in the era of targeted treatments: insights from molecular biology.
Dewulf J, Vangestel C, Verhoeven Y, van Dam P, Elvas F, Van den Wyngaert T, Clézardin P. Dewulf J, et al. Among authors: verhoeven y. Q J Nucl Med Mol Imaging. 2019 Jun;63(2):98-111. doi: 10.23736/S1824-4785.19.03203-5. Epub 2019 Jul 11. Q J Nucl Med Mol Imaging. 2019. PMID: 31298015 Free article. Review.
Immuno-PET Molecular Imaging of RANKL in Cancer.
Dewulf J, Vangestel C, Verhoeven Y, De Waele J, Zwaenepoel K, van Dam PA, Elvas F, Van den Wyngaert T. Dewulf J, et al. Among authors: verhoeven y. Cancers (Basel). 2021 Apr 30;13(9):2166. doi: 10.3390/cancers13092166. Cancers (Basel). 2021. PMID: 33946410 Free PMC article.
12 results